Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $12.22 and last traded at $12.22, with a volume of 861 shares trading hands. The stock had previously closed at $11.4850.
Santen Pharmaceutical Stock Performance
The stock has a 50 day moving average price of $10.97 and a 200 day moving average price of $10.62. The company has a market capitalization of $3.93 billion and a P/E ratio of 0.10.
Santen Pharmaceutical Company Profile
Santen Pharmaceutical Co, Ltd. is a Japan‐based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over‐the‐counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post‐operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.
With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.
Recommended Stories
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
